# Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer

> **NCT02745639** · PHASE2 · COMPLETED · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 18 (actual)

## Conditions studied

- Rectal Neoplasms

## Interventions

- **RADIATION:** VMAT-SIB
- **DRUG:** XELOX

## Key facts

- **NCT ID:** NCT02745639
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2013-11
- **Final completion:** 2015-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02745639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02745639, "Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT02745639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*